Blau Farmacêutica Income Statement

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,702	1,754	1,373	1,407	1,366
Revenue Growth (YoY)	-2.96%	27.81%	-2.44%	2.96%	15.62%
Cost of Revenue	1,020	1,096	882.38	739.03	700.47
Gross Profit	682.74	658.75	490.25	667.88	665.93
Selling, General & Admin	352.99	313.77	150.28	213.85	201.77
Other Operating Expenses	-24.64	16.19	-117.75	1.83	5.41
Operating Expenses	328.35	329.95	41.97	215.69	209.31
Operating Income	354.39	328.8	448.28	452.19	456.62
Interest Expense	-71.88	-58.31	-32.11	-32.43	-26.8
Interest & Investment Income	48.07	46.69	55.8	70.22	34.95
Earnings From Equity Investments	-	-	0.16	-	-
Currency Exchange Gain (Loss)	21.69	-18.89	-8.6	-4.45	1.23
Other Non Operating Income (Expenses)	36.21	-6.39	-10.3	-16.97	16.46
EBT Excluding Unusual Items	388.47	291.89	453.23	468.56	482.47
Other Unusual Items	-	-	-119	-	-
Pretax Income	388.47	291.89	334.23	468.56	482.47
Income Tax Expense	91.7	78.36	86.74	108.07	158.6
Earnings From Continuing Operations	296.77	213.53	247.49	360.49	323.86
Minority Interest in Earnings	-1.82	3.68	2.32	2.88	1.36
Net Income	294.96	217.21	249.81	363.37	325.22
Net Income to Common	294.96	217.21	249.81	363.37	325.22
Net Income Growth	35.80%	-13.05%	-31.25%	11.73%	27.87%
Shares Outstanding (Basic)	231	231	231	231	233
Shares Outstanding (Diluted)	231	231	231	231	233
Shares Change (YoY)	-	-	-0.08%	-0.87%	13.84%
EPS (Basic)	1.28	0.94	1.08	1.57	1.39
EPS (Diluted)	1.28	0.94	1.08	1.57	1.39
EPS Growth	35.80%	-13.05%	-31.18%	12.69%	12.33%
Free Cash Flow	28.8	364.53	71.14	29.24	5.93
Free Cash Flow Per Share	0.13	1.58	0.31	0.13	0.03
Dividend Per Share	-	-	0.295	0.495	-
Dividend Growth	-	-	-40.40%	-	-
Gross Margin	40.11%	37.55%	35.72%	47.47%	48.74%
Operating Margin	20.82%	18.74%	32.66%	32.14%	33.42%
Profit Margin	17.33%	12.38%	18.20%	25.83%	23.80%
Free Cash Flow Margin	1.69%	20.78%	5.18%	2.08%	0.43%
EBITDA	405.37	368.91	478.15	469.62	474.85
EBITDA Margin	23.81%	21.03%	34.83%	33.38%	34.75%
D&A For EBITDA	50.98	40.11	29.87	17.43	18.22
EBIT	354.39	328.8	448.28	452.19	456.62
EBIT Margin	20.82%	18.74%	32.66%	32.14%	33.42%
Effective Tax Rate	23.61%	26.85%	25.95%	23.06%	32.87%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.